Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2019

View Archived Issues

New model explains neural basis of alternating bilateral sensory stimulation for fear disorders

Stress hormones help metastasis along

How the other half controls appetite

Clotting protein cuts neuromuscular synapses, if it can

SunRegen Healthcare presents data on SRG-003 in monkeys with optic atrophy

Preclinical PK/PD studies help determine first-in-human dose of RG-7827

JP-1366 demonstrates safety and favorable PK in healthy subjects

FDA approves sNDA for Avycaz for pediatric patients with cUTI and cIAI

FDA clears Zenith Epigenetics' IND application for ZEN-3694 in TNBC program

Idorsia patents antibacterial pyrroloimidazolones

Novartis patent describes compounds for cancer

Asceneuron discloses OGA inhibitors

Sprint Bioscience synthesizes PIK3C3 inhibitors

TIME-2b study of AKB-9778 in diabetic retinopathy does not meet primary endpoint

ACADIA Pharmaceuticals presents 5-HT2A receptor ligands

Pascal Biosciences and Mitacs partner to support cancer research project at UBC

FDA approves Tecentriq with chemotherapy for first-line treatment of extensive-stage SCLC

Clinical data reported for litoxetine in mixed urinary incontinence

First subject dosed in phase II study of GRF-6019 in patients with severe Alzheimer's disease

Nicox opens phase II trial of NCX-4251 in blepharitis

NAMPT might predict docetaxel resistance in prostate cancer

First-in-human results for miltuximab described, theranostic trial of 89Zr/177Lu-miltuximab planned

Emergent BioSolutions initiates phase III study of anthrax vaccine AV-7909

Moleculin Biotech enrolls first patients in European trial of WP-1220 for CTCL

Crinetics initiates phase II program for CRN-00808 in acromegaly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...